NVAX
Price
$7.10
Change
+$0.06 (+0.85%)
Updated
Jul 10 closing price
Capitalization
1.14B
26 days until earnings call
RXRX
Price
$5.71
Change
+$0.13 (+2.33%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
2.42B
32 days until earnings call
Interact to see
Advertisement

NVAX vs RXRX

Header iconNVAX vs RXRX Comparison
Open Charts NVAX vs RXRXBanner chart's image
Novavax
Price$7.10
Change+$0.06 (+0.85%)
Volume$2.97M
Capitalization1.14B
Recursion Pharmaceuticals
Price$5.71
Change+$0.13 (+2.33%)
Volume$116.21K
Capitalization2.42B
NVAX vs RXRX Comparison Chart in %
Loading...
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVAX vs. RXRX commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVAX is a StrongBuy and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (NVAX: $7.10 vs. RXRX: $5.72)
Brand notoriety: NVAX: Notable vs. RXRX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVAX: 31% vs. RXRX: 104%
Market capitalization -- NVAX: $1.14B vs. RXRX: $2.42B
NVAX [@Biotechnology] is valued at $1.14B. RXRX’s [@Biotechnology] market capitalization is $2.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVAX’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • NVAX’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both NVAX and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVAX’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 5 bullish TA indicator(s).

  • NVAX’s TA Score: 4 bullish, 5 bearish.
  • RXRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than NVAX.

Price Growth

NVAX (@Biotechnology) experienced а +4.41% price change this week, while RXRX (@Biotechnology) price change was +8.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

NVAX is expected to report earnings on Nov 05, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.42B) has a higher market cap than NVAX($1.14B). NVAX YTD gains are higher at: -11.692 vs. RXRX (-15.459). NVAX has higher annual earnings (EBITDA): 555M vs. RXRX (-524.77M). NVAX has more cash in the bank: 731M vs. RXRX (500M). RXRX has less debt than NVAX: RXRX (92.9M) vs NVAX (229M). NVAX has higher revenues than RXRX: NVAX (1.22B) vs RXRX (59.8M).
NVAXRXRXNVAX / RXRX
Capitalization1.14B2.42B47%
EBITDA555M-524.77M-106%
Gain YTD-11.692-15.45976%
P/E Ratio2.58N/A-
Revenue1.22B59.8M2,032%
Total Cash731M500M146%
Total Debt229M92.9M247%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
32
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVAXRXRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 11 days ago
89%
Bearish Trend 18 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JCVIX25.39N/A
N/A
JHancock Classic Value I
MUTHX26.75N/A
N/A
Franklin Mutual Shares Z
SRIDX14.24N/A
N/A
Gabelli SRI I
AGSCX6.21N/A
N/A
Alger Small Cap Growth C
EIVDX15.68N/A
N/A
Allspring Special Large Cap Value Admin